Extensive Product Profile: Understanding Humenotropin 150iu Injection Humenotropin 150iu contains highly purified Menotrophin (Human Menopausal Gonadotropin or hMG), providing a clinically balanced ratio of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). Extracted and refined under pristine global pharmaceutical conditions, this highly potent hormonal injection is an essential component of advanced reproductive medicine, mimicking natural pituitary signals to manage complex ovulation issues and support reproductive care. 1. Clinical Indications & Usage Ovulation Induction: Recommended for women experiencing anovulatory infertility (where the ovaries do not release an egg) or severe irregular cycles who have not achieved results with first-line oral fertility treatments. Hypogonadotropic Hypogonadism in Men: Indicated for men with underlying secondary testicular deficiencies or low gonadotropin signaling to help promote the generation of vital natural hormones and physical development. 2. Mechanism of Action: How Humenotropin Works Follicular Growth Activation (FSH Properties): In females, the FSH component targets and binds to follicle-stimulating hormone receptors located on the granulosa cells of the ovaries. This drives the physical recruitment, ongoing nourishment, and enlargement of healthy fluid-filled sacs (follicles) that house developing eggs. Estrogen Maturation & Release Trigger (LH Properties): The LH component interacts with neighboring cells to promote local estrogen production. Once clinical tracking shows the follicles have reached a mature structure, a secondary hormonal trigger (such as hCG) is given to replicate the natural mid-cycle LH surge, causing the egg to release. 3. Administration and Dosing Guide Administration Route: Humenotropin 150iu is designed strictly for Subcutaneous (SC) or Intramuscular (IM) injection. It should never be taken orally or through an intravenous line. Administration Route: Humenotropin 150iu is designed strictly for Subcutaneous (SC) or Intramuscular (IM) injection. It should never be taken orally or through an intravenous line. Standard Treatment Schedules: For Ovarian Stimulation: Starting doses typically run from 75 IU to 150 IU daily, beginning during the first few days of the menstrual cycle. Doses are dynamically altered by a reproductive specialist over a course of 7 to 12 days based on regular tracking. For Male Fertility Protocols: The standard course consists of 75 IU to 150 IU injected 2 to 3 times per week, often continued over several months and paired with human chorionic gonadotropin (hCG) injections to get a full therapeutic response. ⚠️ Safety, Side Effects, and Monitoring Ovarian Hyperstimulation Syndrome (OHSS): Over-stimulation can lead to OHSS, a critical medical condition where the ovaries become swollen and fluid shifts into the abdominal space. Patients must seek immediate medical care if they experience severe pelvic pain, distinct abdominal bloating, rapid weight gain, nausea, or shortness of breath. Multi-Fetal Pregnancy Risks: Follicular induction significantly increases the probability of conceiving twins, triplets, or multiple gestations compared to natural conception pathways. Common Side Effects: Local injection site discomfort (redness, bruising, or swelling), mild headaches, pelvic heaviness, abdominal cramping, transient nausea, and breast tenderness. 📦 Storage and Handling Specifications Storage Framework: Keep un-reconstituted Humenotropin 150iu injection vials stored inside a clinical refrigerator between 2°C and 8°C (36°F to 46°F). Avoid freezing the product, and do not use vials if they have been frozen. Environmental Protection: Keep the product enclosed in its original box packaging to protect the sensitive powder from direct light and thermal shifts. Dispose of all syringes, needles, and empty glass vials immediately into an approved medical sharps container. Keep out of reach of children and pets. 📄 Regulatory and Clinical Verification Document Pack Authentic Product Profile Analysis Verified Batch Origin Dossier Clinical Quality Evaluation Dossier PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: This profile is compiled strictly for educational, scientific, and patient research purposes. Humenotropin 150 I is an advanced injectable hormone therapy available exclusively under authorized professional supervision (PRESCRIPTION MEDICINE IS YES). 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383